Cti Biopharm Corp. (CTIC) stock rises during current market trading. Let’s find out why?
Cti Biopharm Corp. (NASDAQ: CTIC) stock gains by 6.69% in the current market trading session. CTIC is a biopharmaceutical business focusing on the acquisition, development, and commercialization of innovative targeted medicines for blood-related malignancies that provide patients and healthcare providers with a distinct advantage. CTIC focus its efforts on medicines for malignancies of the blood, […]